PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
79 hedge funds and large institutions have $224M invested in Progenics Pharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 79 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
79
Holders Change
+79
Holders Change %
–
% of All Funds
2.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
79
Increased
–
Reduced
–
Closed
–
Calls
$81K
Puts
$1.83M
Net Calls
-$1.75M
Net Calls Change
-$1.75M
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
U
76
UBS
Zurich,
Switzerland
| $8K | +$8K | +1,750 | New |
|
77
BlackRock
New York
| $7K | +$7K | +1,497 | New |
|
|
TRCT
78
Tower Research Capital (TRC)
New York
| $1K | +$1K | +200 | New |
|
79
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$1K | +300 | New |
|